Calogero Camma'
0000-0002-9224-1914
9 papers found
Refreshing results…
Early hepatic decompensation identifies patients with hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab or Sorafenib at highest risk of death
Liver‐related and extrahepatic events in patients with non‐alcoholic fatty liver disease: a retrospective competing risks analysis
Hepatotoxicity of systemic therapies for unresectable hepatocellular carcinoma
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis
Are radiological endpoints surrogate outcomes of overall survival in hepatocellular carcinoma treated with transarterial chemoembolization?
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19
Should we cure hepatitis C virus in patients with hepatocellular carcinoma while treating cancer?
Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study
Missing publications? Search for publications with a matching author name.